Reaktionsgleichung
[CH:1]1([CH2:4][O:5][C:6]2[N:11]=[C:10]([C:12]([NH:14][C:15]([CH2:21][CH3:22])([CH2:19][CH3:20])[C:16]([OH:18])=O)=[O:13])[CH:9]=[CH:8][C:7]=2[C:23]([F:26])([F:25])[F:24])[CH2:3][CH2:2]1.Cl.[CH3:28][NH2:29]>>[CH2:21]([C:15]([NH:14][C:12]([C:10]1[CH:9]=[CH:8][C:7]([C:23]([F:24])([F:26])[F:25])=[C:6]([O:5][CH2:4][CH:1]2[CH2:2][CH2:3]2)[N:11]=1)=[O:13])([C:16](=[O:18])[NH:29][CH3:28])[CH2:19][CH3:20])[CH3:22]Komponenten
3
Versuchsvorschrift
The title compound was synthesized in analogy to Example 1, using 2-(6-(cyclopropylmethoxy)-5-(trifluoromethyl)picolinamido)-2-ethylbutanoic acid and methanamine hydrochloride as starting materials. MS (EI): m/e=388.0 [M+H]+.
Quellen und Nachweise
- ORD-Eintrag
- ord-bf0a36facefe4e6bba36c5cd546983c1
- Quelldatensatz
- uspto-grants-2016_04
- Patentnummer
- US09321727B2
Verknüpfte Notizen
Wird geladen…